BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 75 filers reported holding BRIDGEBIO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,023,272 | +33.9% | 152,570 | -12.7% | 0.00% | 0.0% |
Q2 2023 | $3,004,513 | +113.9% | 174,681 | +106.1% | 0.00% | 0.0% |
Q1 2023 | $1,404,956 | -48.8% | 84,738 | -76.5% | 0.00% | 0.0% |
Q4 2022 | $2,742,270 | +3016.2% | 359,878 | +3983.5% | 0.00% | – |
Q3 2022 | $88,000 | -95.6% | 8,813 | -96.0% | 0.00% | -100.0% |
Q2 2022 | $2,008,000 | -55.2% | 221,077 | -50.0% | 0.00% | 0.0% |
Q1 2022 | $4,487,000 | +266.3% | 442,040 | +502.3% | 0.00% | – |
Q4 2021 | $1,225,000 | -76.8% | 73,387 | -34.9% | 0.00% | -100.0% |
Q3 2021 | $5,283,000 | +296.3% | 112,725 | +415.3% | 0.00% | – |
Q2 2021 | $1,333,000 | +62.2% | 21,875 | +64.0% | 0.00% | – |
Q1 2021 | $822,000 | -39.5% | 13,341 | -30.2% | 0.00% | – |
Q4 2020 | $1,359,000 | +98.1% | 19,118 | +4.5% | 0.00% | – |
Q3 2020 | $686,000 | +8.7% | 18,295 | -5.4% | 0.00% | – |
Q2 2020 | $631,000 | +36.6% | 19,344 | +21.5% | 0.00% | – |
Q1 2020 | $462,000 | -26.9% | 15,920 | -11.8% | 0.00% | – |
Q4 2019 | $632,000 | -12.6% | 18,041 | -46.5% | 0.00% | – |
Q3 2019 | $723,000 | +4418.8% | 33,699 | +5516.5% | 0.00% | – |
Q2 2019 | $16,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |